Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simone Riek

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Molecular Pharmacology|October 29, 2008
Allosteric LFA-1 inhibitors modulate natural killer cell functionGabriele Weitz-Schmidt, Stéphanie Chreng, Simone Riek
Chemmedchem|May 20, 2026
A 24-Day MicroCycle Journey to Interleukin-17 Inhibitors: From Library Design to Central Core Prioritization and Capping Group IdentificationSophie Racine, Odile Decoret, Marco Palmieri, et al.
Journal of Medicinal Chemistry|December 8, 2025
Harnessing Glutamine-117 Plasticity toward Structure-Based Identification of Triazole IL-17 InhibitorsMatthias R Bauer, Juraj Velcicky, Alban Goetz, et al.
Chemmedchem|December 23, 2024
Thiazole-Based IL-17 Inhibitors Discovered by Scaffold MorphingJuraj Velcicky, Estelle Ngo, Matthias R Bauer, et al.
Biochemical Pharmacology|January 24, 2023
Discovery of a novel, highly potent and orally bioavailable pyrrolidinone indole series of irreversible Myeloperoxidase (MPO) inhibitorsJean B Regard, Tyler J Harrison, Jake Axford, et al.
Journal of Medicinal Chemistry|September 14, 2024
Discovery and <i>In Vivo</i> Exploration of 1,3,4-Oxadiazole and α-Fluoroacrylate Containing IL-17 InhibitorsJuraj Velcicky, Matthias R Bauer, Achim Schlapbach, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Molecular Pharmacology|October 29, 2008
Allosteric LFA-1 inhibitors modulate natural killer cell functionGabriele Weitz-Schmidt, Stéphanie Chreng, Simone Riek
Chemmedchem|May 20, 2026
A 24-Day MicroCycle Journey to Interleukin-17 Inhibitors: From Library Design to Central Core Prioritization and Capping Group IdentificationSophie Racine, Odile Decoret, Marco Palmieri, et al.
Journal of Medicinal Chemistry|December 8, 2025
Harnessing Glutamine-117 Plasticity toward Structure-Based Identification of Triazole IL-17 InhibitorsMatthias R Bauer, Juraj Velcicky, Alban Goetz, et al.
Chemmedchem|December 23, 2024
Thiazole-Based IL-17 Inhibitors Discovered by Scaffold MorphingJuraj Velcicky, Estelle Ngo, Matthias R Bauer, et al.
Biochemical Pharmacology|January 24, 2023
Discovery of a novel, highly potent and orally bioavailable pyrrolidinone indole series of irreversible Myeloperoxidase (MPO) inhibitorsJean B Regard, Tyler J Harrison, Jake Axford, et al.
Journal of Medicinal Chemistry|September 14, 2024
Discovery and <i>In Vivo</i> Exploration of 1,3,4-Oxadiazole and α-Fluoroacrylate Containing IL-17 InhibitorsJuraj Velcicky, Matthias R Bauer, Achim Schlapbach, et al.
Pageof 1